BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2760170)

  • 1. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly.
    van Liessum PA; Hopman WP; Pieters GF; Jansen JB; Smals AG; Rosenbusch G; Kloppenborg PW; Lamers CB
    J Clin Endocrinol Metab; 1989 Sep; 69(3):557-62. PubMed ID: 2760170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment.
    Hopman WP; Van Liessum PA; Pieters GF; Jansen JB; Lamers CB; Smals AG; Rosenbusch G; Kloppenborg PW
    Dig Dis Sci; 1992 Nov; 37(11):1685-90. PubMed ID: 1425066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly.
    Stolk MF; van Erpecum KJ; Koppeschaar HP; de Bruin WI; Jansen JB; Lamers CB; van Berge Henegouwen GP
    Gut; 1993 Jun; 34(6):808-13. PubMed ID: 8314514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial exocrine pancreatic function during long-term treatment with the somatostatin analogue SMS 201-995 in acromegalic patients.
    Van Liessum PA; Hopman WP; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB
    Eur J Clin Invest; 1990 Aug; 20(4):348-53. PubMed ID: 2121494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201-995).
    Hopman WP; van Liessum PA; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB; Kloppenborg PW
    Digestion; 1990; 45 Suppl 1():72-6. PubMed ID: 2185969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
    Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S
    Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
    Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
    Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.
    Newman CB; Melmed S; Snyder PJ; Young WF; Boyajy LD; Levy R; Stewart WN; Klibanski A; Molitch ME; Gagel RF
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2768-75. PubMed ID: 7673422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of cholecystokinin and gallbladder contraction before and after gastrectomy.
    Inoue K; Fuchigami A; Hosotani R; Kogire M; Huang YS; Miyashita T; Suzuki T; Tsuda K; Seino Y; Rayford PL
    Ann Surg; 1987 Jan; 205(1):27-32. PubMed ID: 3800460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients.
    Shi YF; Zhu XF; Harris AG; Zhang JX; Dai Q
    J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B; Mawe GM; Riepl RL
    Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
    Barkan AL; Kelch RP; Hopwood NJ; Beitins IZ
    J Clin Endocrinol Metab; 1988 Jan; 66(1):16-23. PubMed ID: 2891720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-acting somatostatin analogue (octreotide, SMS 201-995) plus calcium channel blocker (verapamil) on gallbladder contraction.
    Kapîcîoglu S; Sentürk O; Ilgün K; Ovali E
    Hepatogastroenterology; 1998; 45(20):420-3. PubMed ID: 9638417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly.
    Ewins DL; Javaid A; Coskeran PB; Shah S; Butler J; Deprez PH; Miell J; Calam J; Barrett JJ; Dawson JM
    Q J Med; 1992 Apr; 83(300):295-306. PubMed ID: 1631261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallbladder motility and cholecystokinin secretion in chronic pancreatitis: relationship with exocrine pancreatic function.
    Gielkens HA; Eddes EH; Vecht J; van Oostayen JA; Lamers CB; Masclee AA
    J Hepatol; 1997 Aug; 27(2):306-12. PubMed ID: 9288605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of somatostatin on postprandial gallbladder relaxation.
    Vu MK; Van Oostayen JA; Biemond I; Masclee AA
    Clin Physiol; 2001 Jan; 21(1):25-31. PubMed ID: 11168293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulated gastrointestinal hormone release and gallbladder contraction during continuous jejunal feeding in patients with pancreatic pseudocyst is inhibited by octreotide.
    Takács T; Hajnal F; Németh J; Lonovics J; Pap A
    Int J Pancreatol; 2000 Dec; 28(3):215-20. PubMed ID: 11373059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
    Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
    Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.